UCReliance#1265: A Phase I/II Study of PiC-D (Ixazomib in Combination with Pomalidomide, Clarithromycin and Dexamethasone) in Patients with Double Refractory Multiple Myeloma

UCI-14-96
NCT02542657
Cancer - Multiple Myeloma
Elizabeth A Brem
Open
Treatment
Clarithromycin, Dexamethasone, Ixazomib, Pomalidomide
I/II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.